LakeShore Biopharma Gets Nasdaq Delisting Notice

MT Newswires Live

Sep 12

LakeShore Biopharma (LSB) said Friday it received a staff determination letter from the Nasdaq Stock Market indicating an intention to delist its securities from the exchange after it was found to be out of compliance with Nasdaq Listing Rules after the closing bid price for its ordinary shares fell below $1.00 per share for 30 consecutive business days.

The company is not eligible for the standard 180-day compliance period since it effected a stock split in the past year.

According to LakeShore, unless it requests an appeal, trading in its securities will be suspended on Sept. 22, and further steps will be taken to remove its securities from listing and registration on Nasdaq.

The company said it was considering available options.

LakeShore Biopharma shares were down 2% in recent premarket activity.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2566971573"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2566971573\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2566971573?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-09-12 20:37","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2566971573","market":"sh","top_or_hot":-1,"title":"LakeShore Biopharma Gets Nasdaq Delisting Notice","media":"MT Newswires Live","content":"<html><body><p> <a href=\"https://laohu8.com/S/LSB\">LakeShore Biopharma</a> (LSB) said Friday it received a staff determination letter from the Nasdaq Stock Market indicating an intention to delist its securities from the exchange after it was found to be out of compliance with Nasdaq Listing Rules after the closing bid price for its ordinary shares fell below $1.00 per share for 30 consecutive business days.</p><p>The company is not eligible for the standard 180-day compliance period since it effected a stock split in the past year.</p><p>According to LakeShore, unless it requests an appeal, trading in its securities will be suspended on Sept. 22, and further steps will be taken to remove its securities from listing and registration on Nasdaq.</p><p>The company said it was considering available options.</p><p>LakeShore Biopharma shares were down 2% in recent premarket activity.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>LakeShore Biopharma Gets Nasdaq Delisting Notice</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLakeShore Biopharma Gets Nasdaq Delisting Notice\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-09-12 20:37</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> <a href=\"https://laohu8.com/S/LSB\">LakeShore Biopharma</a> (LSB) said Friday it received a staff determination letter from the Nasdaq Stock Market indicating an intention to delist its securities from the exchange after it was found to be out of compliance with Nasdaq Listing Rules after the closing bid price for its ordinary shares fell below $1.00 per share for 30 consecutive business days.</p><p>The company is not eligible for the standard 180-day compliance period since it effected a stock split in the past year.</p><p>According to LakeShore, unless it requests an appeal, trading in its securities will be suspended on Sept. 22, and further steps will be taken to remove its securities from listing and registration on Nasdaq.</p><p>The company said it was considering available options.</p><p>LakeShore Biopharma shares were down 2% in recent premarket activity.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"IE00BGHQF748.EUR","symbol_name":"GUINNESS GLOBAL MONEY MANAGERS \"C\" (EUR) ACC","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2566971573","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2566971573","pubTimestamp":1757680637,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"LakeShore Biopharma  said Friday it received a staff determination letter from the Nasdaq Stock Market indicating an intention to delist its securities from the exchange after it was found to be out of compliance with Nasdaq Listing Rules after the closing bid price for its ordinary shares fell below $1.00 per share for 30 consecutive business days.The company is not eligible for the standard 180-day compliance period since it effected a stock split in the past year.According to LakeShore, unless it requests an appeal, trading in its securities will be suspended on Sept. 22, and further steps will be taken to remove its securities from listing and registration on Nasdaq.The company said it was considering available options.LakeShore Biopharma shares were down 2% in recent premarket activity.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"IE00BGHQF748.EUR":"GUINNESS GLOBAL MONEY MANAGERS \"C\" (EUR) ACC","LU2210150020.SGD":"Natixis Thematics Subscription Economy R/A SGD","LU2095319765.USD":"Natixis Thematics Subscription Economy R/A USD","NDAQ":"纳斯达克OMX交易所","BK4139":"生物科技","IE00BKPKM429.USD":"NEUBERGER BERMAN GLOBAL SUSTAINABLE EQUITY \"A\" (USD) ACC","BK4112":"金融交易所和数据",".IXIC":"NASDAQ Composite","LU0314104364.USD":"MANULIFE GF AMERICAN GROWTH \"AA\" (USD) INC","IE00B64PRP62.GBP":"GUINNESS GLOBAL MONEY MANAGERS \"C\" (GBP) ACC","LU2210149790.SGD":"Natixis Thematics Subscription Economy R/A SGD-H","BK4588":"碎股","LSB":"LakeShore Biopharma Co., Ltd.","IE00B3QW5Z07.USD":"GUINNESS GLOBAL MONEY MANAGERS \"C\" (USD) ACC","BK4585":"ETF&股票定投概念"},"translate_title":"LakeShore Biopharma收到纳斯达克退市通知","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{".IXIC":1,"LSB":0.9,"NDAQ":1,"NQmain":1},"content_text":"LakeShore Biopharma (LSB) said Friday it received a staff determination letter from the Nasdaq Stock Market indicating an intention to delist its securities from the exchange after it was found to be out of compliance with Nasdaq Listing Rules after the closing bid price for its ordinary shares fell below $1.00 per share for 30 consecutive business days.The company is not eligible for the standard 180-day compliance period since it effected a stock split in the past year.According to LakeShore, unless it requests an appeal, trading in its securities will be suspended on Sept. 22, and further steps will be taken to remove its securities from listing and registration on Nasdaq.The company said it was considering available options.LakeShore Biopharma shares were down 2% in recent premarket activity.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}